Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Support Care Cancer. 2020 May 6;29(1):387–396. doi: 10.1007/s00520-020-05473-2

Figure 3.

Figure 3.

Figure 3.

Mean percent of baseline hot flash score for the entire treatment group (A) and the subset of patients who received the subcutaneous testosterone preparation (B).